NIVALIS THERAPEUTICS INC COM USD0.001


Updates from The Motley Fool

Latest updates on Nivalis Therapeutics from Fool.com.

There is no available coverage of Nivalis Therapeutics at this time.



Stock Performance

NVLS vs. S&P 500 | 2 Year Performance
View Interactive NVLS Charts
Sponsored by

Key Data Points

Primary metrics and data points about Nivalis Therapeutics.
Current Price: $6.40
Prev Close: $6.20
Open: $6.19
Bid: $5.32
Ask: $6.97
Day's Range: $6.18 - $6.40
52wk Range: $3.68 - $18.59
Volume: 16,956
Avg Vol 30,282
Market Cap: $98.89M
P/E (ttm): -20.67
EPS (ttm): -$0.30
Div & Yield: $0.00 (0.0%)

Company Rating

What our community thinks about Nivalis Therapeutics.
CAPS Rating 0 out of 5
 
5 Outperform
2 Underperform
CAPS All Stars
 
1 Outperform
1 Underperform

How do you think Nivalis Therapeutics will perform against the market?



You pick for Nivalis Therapeutics is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


Business Summary

Industry, sector and description for Nivalis Therapeutics.

NIVALIS THERAPEUTICS INC COM USD0.001

  • Exchange: NASDAQ